By PPN News Staff
Fresenius Kabi announced the immediate availability in the United States of caspofungin acetate for injection in a room temperature–stable formulation.
Caspofungin is available in two presentations: 50 mg per vial and 70 mg per vial.
Caspofungin is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for empirical therapy for presumed fungal infections in febrile and neutropenic patients. It is indicated for the treatment of